Xceed Revenue and Competitors
Estimated Revenue & Valuation
- Xceed's estimated annual revenue is currently $8.3M per year.
- Xceed's estimated revenue per employee is $126,000
Employee Data
- Xceed has 66 Employees.
- Xceed grew their employee count by 35% last year.
Xceed's People
Name | Title | Email/Phone |
---|---|---|
1 | Co-Founder & CTO | Reveal Email/Phone |
2 | Chief Technology Officer | Reveal Email/Phone |
3 | Head Talent | Reveal Email/Phone |
4 | Country Manager France | Reveal Email/Phone |
5 | Key Account Manager | Reveal Email/Phone |
6 | Customer Success Specialist | Reveal Email/Phone |
7 | Logotipo de Xceed Senior Frontend Developer | Reveal Email/Phone |
8 | Senior Backend Engineer | Reveal Email/Phone |
9 | Senior Frontend Developer | Reveal Email/Phone |
10 | South African Partnership Lead | Reveal Email/Phone |
Xceed Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $2.6M | 25 | -4% | N/A | N/A |
#2 | $25.5M | 91 | 6% | N/A | N/A |
What Is Xceed?
N/A
Total Funding
66
Number of Employees
$8.3M
Revenue (est)
35%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Xceed News
2022-04-20 - Porque no todo son SUV (ni compactos): así es el Kia Xceed en oferta por
18.150
Porque no todo son SUV (ni compactos): así es el Kia Xceed en oferta ... Kia tiene la solución en su portfolio con el Xceed, un crossover...
2022-04-17 - Aquasphere Brings Speed & Advanced Technology ...
Oleksiak, known as one of the fastest swimmers in the world and a flagship athlete for Team Aquasphere, trains and races with the XCEED...
2022-04-17 - Lonza : Luzhu Biotech Develops Recombinant Herpes Zoster Vaccine and
Bispecific Antibody using Lonza's GS Xceed® Gene Expression System
Luzhu Biotech entered a licensing agreement to use Lonza's GS Xceed® Gene Expression System with GS piggyBac® transposon technology...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $18.2M | 66 | 6% | N/A |
#2 | $27.6M | 66 | 6% | N/A |
#3 | $15.2M | 66 | 25% | N/A |
#4 | $3.5M | 66 | 5% | N/A |
#5 | $35M | 66 | 20% | N/A |